AGT and cancer: Such stimulatory signals of AGT activation include the pro‐inflammatory cytokine interleukin‐6 and glucocorticosteroids (Wang et al., 2014), which both have been reported to predict poor outcome in bevacizumab‐treated cancer patients (Duerinck et al., 2015; Noonan et al., 2018; Urup et al., 2016a).